Covered recipient · General Payments record
HECTOR QUINTERO
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2024
$1,106.53
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,106.53 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $381.56 | 3 |
| CALLIDITAS THERAPEUTICS US INC. | $247.68 | 2 |
| Amgen Inc. | $230.30 | 2 |
| Relypsa, Inc. | $124.95 | 1 |
| ANI Pharmaceuticals, Inc. | $122.04 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $1,106.53 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $111.59 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111681120 | CMS |
| Amgen Inc. | $118.71 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111681118 | CMS |
| ANI Pharmaceuticals, Inc. | $122.04 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091169182 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $124.92 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141515197 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $122.76 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141523291 | CMS |
| Travere Therapeutics, Inc. | $125.00 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149958093 | CMS |
| Travere Therapeutics, Inc. | $131.56 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149958106 | CMS |
| Travere Therapeutics, Inc. | $125.00 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149958100 | CMS |
| Vifor Pharma, Inc. | $124.95 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124058211 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.